chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 full periods after being menopause for 9 years; migraines; tingling pain all over the body; Headache; face completely numb; neck pain; This spontaneous case was reported by a consumer and describes the occurrence of POSTMENOPAUSAL HAEMORRHAGE (2 full periods after being menopause for 9 years), MIGRAINE (migraines) and PARAESTHESIA (tingling pain all over the body) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hay fever, Drug allergy (reacted to a sulfa drug) and Menopause. Concomitant products included LEVOTHYROXINE for Thyroid disorder.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POSTMENOPAUSAL HAEMORRHAGE (2 full periods after being menopause for 9 years), MIGRAINE (migraines) and PARAESTHESIA (tingling pain all over the body). At the time of the report, POSTMENOPAUSAL HAEMORRHAGE (2 full periods after being menopause for 9 years), MIGRAINE (migraines) and PARAESTHESIA (tingling pain all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional events and outcome updated.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
About 10 minutes  after receiving vaccines, patient walked from exam room to front desk as they were leaving and experienced an episode of going weak, brief confusion, and pallor lasting for about a minute.  Event was consistent with near syncopal episode without loss of consciousness.  Vital signs remained stable.  Patient complained of pain at injection site and Tylenol was given as well as sips of water.  He laid in inclined position for 15 minutes after which he appeared stable and was able to walk without repeat episode.
pt mother her was unable to restrain him well so he moved away and full  dose was wasted. first was  on left deltoid ,  vaccine admistered successfully on right deltoid with no problems.
On about Sept 20, 2007 (three months after immunization) pt started to experience increased muscle tone and hyperesthesia on left side of face, which has persisted. No zosteriform eruption.
local rxn per MD lt arm are 50mm-raised/reddened; ice & further eval to monitor
Flu like symptoms after second dose; Shaking after second dose; Small fever after second dose; Chills after second dose; Second dose administered 8 to 9 weeks after the first dose; Mild headache that lasted 36 hours after second dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after second dose), TREMOR (Shaking after second dose), PYREXIA (Small fever after second dose), CHILLS (Chills after second dose) and HEADACHE (Mild headache that lasted 36 hours after second dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Congenital heart disease NOS.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered 8 to 9 weeks after the first dose). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after second dose), TREMOR (Shaking after second dose), PYREXIA (Small fever after second dose), CHILLS (Chills after second dose) and HEADACHE (Mild headache that lasted 36 hours after second dose). In April 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered 8 to 9 weeks after the first dose) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms after second dose), TREMOR (Shaking after second dose), PYREXIA (Small fever after second dose) and CHILLS (Chills after second dose) outcome was unknown and HEADACHE (Mild headache that lasted 36 hours after second dose) had resolved.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-416038 (Patient Link).
Involuntary movements; Hypnic jerks; Muscle twitching; This is a spontaneous report from a contactable consumer (patient). A 37-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 intramuscular, administered in Arm Left on 27Apr2021 11:30 (age at vaccination 37 years) as dose 1, single for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing. The patient had no allergies. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 07:00 the patient experienced hypnic jerks, muscle twitching, involuntary movements on 01May2021. Patient visited physician office for involuntary movements. Patient did not receive any treatment for hypnic jerks and muscle twitching. Patient received treatment for involuntary movements. Also take medication Citalopram anxiety medication. The outcome of events was unknown for involuntary movements rest of events outcome was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I had a sore arm for a day after receiving the vaccine. I tested positive for COVID-19 on 12/20/2022.  I don't remember taking anything for my symptoms, but I tried to stay hydrated, rest and stayed home.
Appendicitis; This is a spontaneous report from a contactable consumer reporting for her female colleague.  A female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 23Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced appendicitis on an unspecified date and had to have an emergency appendectomy 01Mar2021. She was home and healing. The outcome of the event was unknown.  No follow-up attempts are possible, information on batch number cannot be obtained.
Information has been received from a pharmacist concerning a female who was vaccinated with a dose of hep B virus vaccine rHBsAg (yeast). The pharmacist reported that the pt subsequently developed nausea, vomiting, rash and was deathly ill. Unspecified medical attention was sought and the pt subsequently recovered from her events. Additional information has been requested.
Shingles Narrative: Patient presented to urgent care with a rash 7 days after getting COVID vaccine. Patient's rash was mildly painful ranging from his neck/jaw line to side of the left skull. Patient did have chicken pox a child.
Moderna COVID-19 Vaccine EUA vaccine second dose  about 2 or 3 hrs after shot, I had anaphylactic symptoms on the side of the injection. swelling of throat and tongue, sneezing, coughing, wheezing, trouble breathing.  I was not going to call 911 cause I could still breath on the other side, and I could not drive to hospital to get epinephrine shot so I took 3 or 4 benaydrel every few hours and it finally went away.
Patient was administered Pfizer (12 and up) Purple Top 0.2 ml dose at age 10 which was not correct. Pt did not experience any adverse reaction to this vaccine.
This spontaneous report as received from two nurses refers to a patient of unknown age and gender. On 05-NOV-2014 the patient was vaccinated subcutaneously with an expired dose of PNEUMOVAX 23 (0.5ml, lot # J002646, expiration date 11-MAR-2014). No adverse effects were reported. One of the reported nurses stated that she believed that medication error was due to the expiration date formatted with date-month-year. She additionally reported that expiration date was embossed onto the box and it was always difficult to read. She clarified this box did not look any other box. No PQC (product quality complaint) was reported. Additional information has been requested.
15 hours after shot: swelling and redness in left hand, right arm, and both legs (calves). Prednisone was prescribed but she couldn?t keep it down. Swelling and redness resolved independently within 3-4 days. 5 days after shot, woke up with fever (102), very lethargic. Gave Tylenol, was better for a few hours. Lethargic again in the afternoon, better by the next day.
Swelling/hardness, redness, painful, itching starting day 5, symptoms lasting 1 week
Patient came to the pharmacy about 6pm stating that he felt a little funny after his vaccination and that his right side felt numb.  He was slurring his words and the right side of his face appeared to be drooping.  I suggested we call an ambulance but he refused.  The manager took him to call his wife to go to the emergency room.
Systemic: Headache-Severe, Systemic: Pateint experienced severe throbbing headache 5 minutes after the vaccine. She had shortness of breath due to walking before the vaccination. She had tightness on her chest 40 min latetr. 911 called; symptoms  lasted 1 day
Patient had a flair of her psoriasis/eczema the day after her second vaccine.  She was already symptomatic but had a significant increase that day.   With steroids the flair was able to return under control.
A lot of allergies; Not feeling great on his tongue; Feel growing heat in the arm; Husband's arm blew up or has rashes; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (A lot of allergies), TONGUE DISCOMFORT (Not feeling great on his tongue), FEELING HOT (Feel growing heat in the arm) and RASH (Husband's arm blew up or has rashes) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, the patient experienced FEELING HOT (Feel growing heat in the arm) and RASH (Husband's arm blew up or has rashes). On 19-Aug-2021, the patient experienced TONGUE DISCOMFORT (Not feeling great on his tongue). On an unknown date, the patient experienced ALLERGY TO VACCINE (A lot of allergies). At the time of the report, ALLERGY TO VACCINE (A lot of allergies), TONGUE DISCOMFORT (Not feeling great on his tongue), FEELING HOT (Feel growing heat in the arm) and RASH (Husband's arm blew up or has rashes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant drugs were reported.  No Treatment information  were reported.
Sharp pain - patient described as muscle pain - going from elbow up to her neck. Pain started day following the vaccination and is still 5 days past the vaccination day.
Blurry  vision to the point of not being able to focus on a singular item, sweating,  and vomiting
A report was received from a non healthcare professional  on Nov 10 2005, concerning a female vaccinee aged approximately 85 years old. The vaccine's medical history or concomitant medications was unknown by the reporter. On an unknown date, the vaccine received Fluvirin (batch 61503). On an unknown date the vaccinee developed localized cellulitis and swelling at the injection site. The vaccinee is currently hospitalised and her symptoms are persisting. Follow up information will be sought.
head colds; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The consumer reported for himself and his wife (patient). This is second of two reports.  A female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Mar2021, outcome "unknown", described as "head colds".  Additional information: Product: Pfizer-Biontech Covid-19 Vaccine. The consumer and his wife (patient) had their 1st Pfizer vaccine dose on 10Mar2021, and the next vaccine dose is due tomorrow. The consumer stated he and his wife had head colds, no fever. The patient asked if they should reschedule their 2nd dose and if it is ok to have a cold when they get the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021350558 Same reporter/vaccine/events, different patient
Experiencing pain in left arm starting in elbow. And going down to hand with tingling of all fingers- Worse upon awakening- intermittent during days Motrin gives some relief. Denies rep motion.
Booster - hives & rash, took extra Benadryl - hives worse than I?ve ever had, lasted about 6 days
tested positive for Covid a very mild case; tested positive for Covid a very mild case; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) and on 11Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for Covid a very mild case". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: tested positive for Covid a very mild case.  Clinical information: Patient have received two Covid shots and two Pfizer boosters. Patient had a very sore arm and also tested positive for Covid a very mild case. Unfortunately, soon after Patient had a bad rash on my back and stomach which was diagnosed by his Dermatologist as Bullous Pemphigoid a rare skin disorder but potentially very dangerous to get. patient have read that a few other people have had this same reaction.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I had the 1st shot on Wednesday March 10th. On Sunday the 14th, just before going to bed at about 11pm, I went to pee. The urine was very dark brown. Didn't appear to have any red for blood. The next day I felt like water was being retained and it felt that I couldn't empty the bladder and pee was coming out slower than usual. Late Monday the 15th before bed I peed another dark brown urine and a red blood clot came out. At that point I became very concerned and sent to see the doctor on the 16th. Referred to a kidney specialist for March 31st. Between March 14th to March 29th , somedays I felt like I was retaining water, most days felt like I couldn't empty my bladder with slow flow. With the recent news of the concerns of blood clots with vaccines, I felt that I should report this.
Fever, chills. headache, diarrhea - all within 2 weeks of injection
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021 at 11:11 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). On 22-Jun-2021 at 11:11 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 30.31.  Concomitant products were not provided.  On 22-Jun-2021, excursion time was 08 AM, temperature was 35, total doses given for the day was 36, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 27-May-2021, vial was moved to clinic on 22-Jun-2021. 4 vials were sent to clinic. Vaccine BUD date was 26-Jun-2021.  On 22-Jun-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 35, 9 AM: 39, 10 AM: 47, 11 AM: 36, 12 AM: 42, 1PM: 43, 2 PM: 43, 3 PM: 43, 4 PM: 43 and 5 PM: not provided.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
experiencing shortness of breath; cough; This is a spontaneous report from a contactable consumer or other non-health care professional reporting for wife (Patient).  A 27-year-old female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no/ Lot number: not reported) via an unknown route of administration on an unspecified date as dose 1, single for covid-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, patient experienced with shortness of breath and cough together, after her 1st dose of the vaccine 10 days before. Patient went to the doctor for the resulted events, and she tested for the Covid. Patient did not have these problems until she received her vaccination was reported as no. Investigation Assessment was not provided. On an unknown date, patient underwent lab tests and procedure which were evaluated blood pressure test with unknown results and a COVID test results negative for Sars-cov-2. Reporter mentioned that patient did not have these problems until she received her vaccination. They are evaluating a possible respiratory problem, but it was still too early to conclude. Patient was asking whether the reported events were side effect of vaccine. The outcome of the events was unknown.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained. No further information is expected.
Red spots about 1/4 inch in size, on rright rib cage and stomach. Low grade fever x 3 days,
Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Shakiness-Mild, Systemic: Visual Changes/Disturbances-Severe, Systemic: Weakness-Mild
stomach cramps; rash on her face; This non-serious case was reported by a consumer via call center representative and described the occurrence of stomach cramps in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11-MAR-2023, the patient received the 1st dose of Shingrix. On 11-MAR-2023, less than a day after receiving Shingrix, the patient experienced stomach cramps (Verbatim: stomach cramps) and exanthema facial (Verbatim: rash on her face). The outcome of the stomach cramps and exanthema facial were not recovered/not resolved.   It was unknown if the reporter considered the stomach cramps and exanthema facial to be related to Shingrix.     It was unknown if the company considered the stomach cramps and exanthema facial to be related to Shingrix.   Additional Information: GSK Receipt Date: 23-MAR-2023 The patient self-reported this case. The patient stated that she received her dose of Shingrix and since that time had experienced a rash on her face and stomach cramps.  The reporter did not consent to follow-up.
Symptoms started as a dull headache , chills and myalgia that progressed to an ocular migraine the next morning  and continued for the next 5 days. on the third day of the migraine I saw my PCP and was give  Toradol IM and Zofran for the nausea. this dulled the HA but it returned the next day and remained for 2 more days before decreasing to a dull HA again. I have had a dull HA off and on since then, not a constant HA as initially.